择期子宫切除术和子宫肌瘤剔除术女性术前贫血的风险
这项回顾性、基于人群的队列研究纳入2013至2015年加拿大安大略省因良性指征行择期子宫切除术或子宫肌瘤剔除术的成年女性,发现术前贫血(血红蛋白<12 g/dL)与30天术后不良结局独立相关,尤其在55岁以上女性中风险更高。
要点
- 术前贫血患病率为22.6%(3664/16218)。
- 倾向性匹配后贫血组主要结局发生率为41.2%,非贫血组为36.2%(RR 1.14)。
- 贫血组输血风险显著升高(RR 3.25)。
核心结论
- 择期子宫切除术/子宫肌瘤剔除术女性术前贫血常见,是30天术后不良结局的独立危险因素,尤其见于老年女性。
研究设计与样本
- 回顾性、基于人群的队列研究,纳入2013至2015年加拿大安大略省因良性指征行择期子宫切除术或子宫肌瘤剔除术(腹腔镜/开腹)的成年女性(≥18岁),共16218例。
主要发现
- 队列中3664例(22.6%)有贫血;倾向性匹配后每组3261例,所有基线特征标准化差异<0.10。
- 匹配队列中主要结局(死亡、并发症或再入院)贫血组41.2% vs 非贫血组36.2%(RR 1.14,95%CI 1.07-1.21,P<.0001;绝对风险降低5.03%,95%CI 2.70-7.36;需伤害人数=20)。
- 输血风险贫血组显著更高(RR 3.25,95%CI 2.67-3.95,P<.0001;绝对风险降低8.34%,95%CI 7.06-9.63;需伤害人数=12)。
- 其他次要结局无差异。
- 亚组分析(>55岁 vs ≤55岁,n=736)中,老年女性主要结局风险增加(RR 1.40,95%CI 1.12-1.76,P=.004),输血(RR 4.20,95%CI 1.65-10.72,P=.003)、手术部位感染(RR 1.35,95%CI 1.01-1.81,P=.04)和再入院(RR 2.36,95%CI 1.54-3.62,P<.0001)风险亦增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hysterectomy is one of the most common surgeries performed worldwide. Identification of modifiable risk factors for complications or readmissions could lead to targeted interventions to improve patient care and reduce health care costs. Preoperative anemia has been identified as a risk factor for adverse postoperative outcomes following noncardiac surgery. However, studies have not focused on young and healthy surgical populations, such as women undergoing gynecologic surgery for benign indications. OBJECTIVE: The purpose of this study was to evaluate whether preoperative anemia in women undergoing elective hysterectomy or myomectomy for benign indications was associated with increased 30 day postoperative morbidity and mortality. STUDY DESIGN: In this retrospective, population-based cohort study, we followed up adult women (≥18 years of age) who underwent elective hysterectomy or myomectomy (laparoscopic/laparotomy) between the years 2013 and 2015 for benign indications in Ontario, Canada. We used linked administrative data from a government-administered, single-payer provincial health care system using Canadian Classification of Health Interventions intervention codes, International Classification of Diseases, 10th revision, diagnostic codes, physician billing codes, and laboratory data from both community and hospital laboratories across the province. Our exposure of interest was preoperative anemia, defined as a hemoglobin value <12 g/dL on the complete blood count measured closest to the date of surgery. Our primary outcome was the composite of 30 day postoperative morbidity and mortality. Secondary outcomes were 5 individual components of the primary outcome: death, transfusion, surgical site infection, venothromboembolism, and return to the hospital within 30 days. To adjust for confounding, we generated a propensity score using a multiple logistic regression model in which the presence of anemia was regressed on all baseline characteristics. We matched anemic to nonanemic patients on the logit of the propensity score. Using an unadjusted log-binomial model estimated using generalized estimating equations to account for the matched pairs, we calculated the relative risk, 95% confidence intervals, and P values to evaluate the effect of anemia on outcomes. RESULTS: Of the 16,218 women in the cohort, 3664 (22.6%) had anemia. After propensity matching, standardized differences in all baseline characteristics (n = 3261 per group) were <0.10. In the matched cohort, the primary outcome (death, complications, or readmission) occurred in 41.2% of anemic patients and 36.2% of nonanemic patients (relative risk, 1.14, 95% confidence interval, 1.07-1.21, P < .0001; absolute risk reduction, 5.03%, 95% confidence interval, 2.70-7.36; (number needed to harm = 20). The risk of transfusion was significantly higher in anemic patients (relative risk, 3.25, 95% confidence interval, 2.67-3.95, P < .0001; absolute risk reduction, 8.34%, 95% confidence interval, 7.06-9.63; number needed to harm = 12). There was no difference in other secondary outcomes. In a subgroup analysis (women >55 years vs ≤55, n = 736), older women were at increased risk of the primary outcome (relative risk, 1.40, 95% confidence interval, 1.12-1.76, P = .004), transfusion (relative risk, 4.20, 95% confidence interval, 1.65-10.72, P = .003), surgical site infection (relative risk, 1.35, 95% confidence interval, 1.01-1.81, P = .04), and return to the hospital (relative risk, 2.36, 95% confidence interval, 1.54-3.62, P < .0001). CONCLUSION: Preoperative anemia in women undergoing elective hysterectomy/myomectomy was common and is an independent risk factor for 30 day postoperative adverse outcomes, especially in older women.
引用
- Murji A, Lam M, Allen B, et al. Risks of preoperative anemia in women undergoing elective hysterectomy and myomectomy. Am J Obstet Gynecol. 2019. PMID: 31310749. doi:10.1016/j.ajog.2019.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。